m6A-centered Disease Response Information
General Information of the Disease (ID: M6ADIS0109)
Name |
Liver disease
|
||||
---|---|---|---|---|---|
ICD |
ICD-11: DB9Z
|
Full List of Target Gene(s) of This m6A-centered Disease Response
DNA damage-inducible transcript 3 protein (DDIT3/CHOP)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | METTL14 promotes DNA damage-inducible transcript 3 protein (DDIT3/CHOP) mRNA decay through its 3' UTR N6-methyladenosine (m6A) to inhibit its downstream pro-apoptotic target gene expression, suppress ER proteotoxic liver disease. UPR induces METTL14 expression by competing against the HRD1-ER-associated degradation (ERAD) machinery to block METTL14 ubiquitination and degradation. | |||
Responsed Disease | Liver disease [ICD-11: DB9Z] | |||
Target Regulator | Methyltransferase-like 14 (METTL14) | WRITER | ||
Target Regulation | Down regulation | |||
Pathway Response | Ubiquitin mediated proteolysis | hsa04120 | ||
Cell Process | Cell apoptosis | |||
Ubiquitination degradation | ||||
In-vitro Model | HEK293 | Normal | Homo sapiens | CVCL_0045 |
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
High mobility group protein B1 (HMGB1)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [2] | |||
Response Summary | ALKBH5-dependent High mobility group protein B1 (HMGB1) expression mediates STING-interferon regulatory factor 3 innate immune response in radiation-induced liver diseases. | |||
Responsed Disease | Liver disease [ICD-11: DB9Z] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Down regulation | |||
Cell Process | Immune Response | |||
Cell apoptosis | ||||
Mammalian target of rapamycin complex 1 (mTORC1)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [3] | |||
Response Summary | Mammalian target of rapamycin complex 1 (mTORC1) pathway is highly activated in rbm15-deficient hepatocytes. Rapamycin treatment partially restored normal hepatic gene expression as well as the nuclear location of the transcription factor Hnf4a. Taken together, these results reveal an unexpected role of Rbm15 in liver maturation. | |||
Responsed Disease | Liver disease [ICD-11: DB9Z] | |||
Target Regulator | RNA-binding motif protein 15 (RBM15) | WRITER | ||
Target Regulation | Down regulation | |||
Pathway Response | mTOR signaling pathway | hsa04150 | ||
Cell Process | Cell proliferation and apoptosis | |||
In-vivo Model | Zebrafish (Danio rerio) AB strain-derived Tg(lfabp:Dendra2-NTR)cq1 was used as WT, and rbm15cq96 mutant was generated by ENU treatment. | |||
Stimulator of interferon genes protein (STING1)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [2] | |||
Response Summary | ALKBH5-dependent HMGB1 expression mediates Stimulator of interferon genes protein (STING1)-interferon regulatory factor 3 innate immune response in radiation-induced liver diseases. | |||
Responsed Disease | Liver disease [ICD-11: DB9Z] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Down regulation | |||
Cell Process | Immune Response | |||
Cell apoptosis | ||||
References